Anti-JCV antibody prevalence in a French cohort of MS patients under natalizumab therapy.
Outteryck O, Ongagna JC, Duhamel A, Zéphir H, Collongues N, Lacour A, Fleury MC, Berteloot AS, Blanc F, Giroux M, Vermersch P, de Sèze J.
Outteryck O, et al. Among authors: zephir h.
J Neurol. 2012 Nov;259(11):2293-8. doi: 10.1007/s00415-012-6487-5. Epub 2012 Apr 12.
J Neurol. 2012.
PMID: 22527227